183 related articles for article (PubMed ID: 9572543)
1. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
Jacot JL; Hosotani H; Glover JP; Lois N; Robison WG
J Ocul Pharmacol Ther; 1998 Apr; 14(2):169-80. PubMed ID: 9572543
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.
Hosotani H; Ohashi Y; Kinoshita S; Matsumoto T; Awata T
Curr Eye Res; 1996 Oct; 15(10):1005-7. PubMed ID: 8921238
[TBL] [Abstract][Full Text] [Related]
3. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
[TBL] [Abstract][Full Text] [Related]
4. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats.
Yokoi N; Niiya A; Komuro A; Yokogaki S; Naka H; Awata T; Honma Y; Yamada J; Tei M; Kinoshita S
Curr Eye Res; 1997 Jun; 16(6):595-9. PubMed ID: 9192169
[TBL] [Abstract][Full Text] [Related]
5. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
6. Iris vasculopathy in galactose-fed rats.
Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
[TBL] [Abstract][Full Text] [Related]
7. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
Awata T; Sogo S; Yamamoto Y
Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
[TBL] [Abstract][Full Text] [Related]
8. Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats.
Awata T; Sogo S; Yamagami Y; Yamamoto Y
J Ocul Pharmacol; 1988; 4(3):195-201. PubMed ID: 3143793
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
Robison WG; Laver NM; Jacot JL; Chandler ML; York BM; Glover JP
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
[TBL] [Abstract][Full Text] [Related]
10. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
Robison WG; Laver NM; Jacot JL; Glover JP
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats.
Kubo E; Nakamura S; Tsuzuki S; Takahashi Y; Akagi Y; Mizuno K; Matsubara A
Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):758-62. PubMed ID: 10447652
[TBL] [Abstract][Full Text] [Related]
12. Effect of aldose reductase inhibitor on corneal epithelial barrier function in galactose-fed dogs.
Kubo E; Mori K; Kobayashi T; Takahashi Y; Yokoi N; Kinoshita S; Kasahara T; Yonezawa H; Akagi Y
J Ocul Pharmacol Ther; 1998 Apr; 14(2):181-90. PubMed ID: 9572544
[TBL] [Abstract][Full Text] [Related]
13. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.
Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
J Ocul Pharmacol Ther; 1995; 11(3):469-87. PubMed ID: 8590278
[TBL] [Abstract][Full Text] [Related]
14. A new approach against sugar cataract through aldose reductase inhibitors.
Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
[TBL] [Abstract][Full Text] [Related]
15. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.
Hosotani H; Ohashi Y; Yamada M; Tsubota K
Am J Ophthalmol; 1995 Mar; 119(3):288-94. PubMed ID: 7872388
[TBL] [Abstract][Full Text] [Related]
16. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
[TBL] [Abstract][Full Text] [Related]
17. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
Sato S; Mori K; Wyman M; Kador PF
Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
[TBL] [Abstract][Full Text] [Related]
19. Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.
Forster HG; ter Wee PM; Hohman TC; Epstein M
Diabetologia; 1996 Aug; 39(8):907-14. PubMed ID: 8858212
[TBL] [Abstract][Full Text] [Related]
20. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
